Neogene Therapeutics - Funding, Financials, Valuation, Investors - Cointime

比特币 ¥632,125.58 +3.92%
以太坊 ¥14,963.14 +4.79%
币安币 ¥4,554.10 +2.18%
Optimism ¥6.49 +7.30%
Arbitrum ¥2.81 +7.98%
Solana ¥1,017.50 +8.72%
Polygon ¥1.56 +2.77%
Cosmos ¥35.32 +5.28%
Avalanche ¥153.56 +10.58%

比特币 ¥632,125.58 +3.92%
以太坊 ¥14,963.14 +4.79%
币安币 ¥4,554.10 +2.18%
Optimism ¥6.49 +7.30%
Arbitrum ¥2.81 +7.98%
Solana ¥1,017.50 +8.72%
Polygon ¥1.56 +2.77%
Cosmos ¥35.32 +5.28%
Avalanche ¥153.56 +10.58%

Neogene Therapeutics

company

Employee Profiles

Number of Employee Profiles

6

Neogene Therapeutics has 6 current employee profiles, including executive Carsten Linnemann

Carsten Linnemann

executive

executive

Kanti Thirumoorthy

executive

employee

executive

Raphael F. Rousseau

executive